Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/22921
Title: Ustekinumab is a safe and effective biologic agent for Crohn's disease in a Liver Transplant patient.
Austin Authors: Peverelle, Matthew R ;Asadi, Khashayar ;De Cruz, Peter P 
Affiliation: Anatomical Pathology
Gastroenterology and Hepatology
Medicine (University of Melbourne)
Issue Date: 5-Oct-2020
Date: 2020-03-31
Publication information: Journal of Crohn's & Colitis 2020; 14(10): 1498-1499
URI: https://ahro.austin.org.au/austinjspui/handle/1/22921
DOI: 10.1093/ecco-jcc/jjaa062
ORCID: 0000-0003-0136-6699
0000-0002-3399-7236
Journal: Journal of Crohn's & Colitis
PubMed URL: 32232397
Type: Journal Article
Subjects: Crohn’s disease
Liver transplantation
Ustekinumab
Appears in Collections:Journal articles

Show full item record

Page view(s)

18
checked on Apr 12, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.